- Login
- Register & Subscribe
- Language: EN FR DE
Research & University News
New awards for Parkinson’s disease treatments
Monday 30 November 2009
The Michael J. Fox Foundation has awarded $1.5 million to six international research teams which are working on potentially disease-modifying therapies for Parkinson’s disease. The programme is financially supported by Elan Corporation Plc.
Location
United States
See map: Google Maps
BioCity Nottingham collaborates with three US science parks
Thursday 19 November 2009
BioCity Nottingham, a bioscience incubator in Britain’s East Midlands, has entered into collaboration agreements with three US regional science parks to promote better transatlantic opportunities for small biotech businesses.
Location
United Kingdom
See map: Google Maps
Katholieke Universiteit Leuven receives biomedical research grant
Monday 26 October 2009
The Katholieke Universiteit Leuven and the Rega Institute for Medical Research, both in Belgium, have announced the receipt of a €2.8 million from the Wellcome Trust to research a treatment for dengue fever.
Location
Belgium
Nobel Prize awarded for telomerase discovery
Saturday 10 October 2009
Three US-based scientists have been awarded the 2009 Nobel Prize in Physiology or Medicine for their work in explaining how chromosomes are copied during cell division and how they are protected against degradation.
Location
Sweden
Sir Greg Winter co-founds new biotechnology company
Wednesday 7 October 2009
Sir Greg Winter, a founder of both Cambridge Antibody Technology and Domantis, has put his scientific and entrepreneurial skills to work again as the scientific co-founder of new company in the UK that is developing mini-antibodies.
Location
United Kingdom
See map: Google Maps
Pharma business model must change, says sanofi-aventis executive
Thursday 24 September 2009
The pharmaceutical industry must move quickly to change its business model in order to be able to deliver new products in the future, Jean-Claude Muller of sanofi-aventis told a meeting of industry executives.
Location
France
Risk factors for prostate cancer identified
Monday 21 September 2009
An international team of scientists has reported finding four new single-letter variations in the sequence of the human genome which confers an increased risk of prostate cancer. The findings were published online in Nature Genetics.
Location
Iceland
Small molecule for treating Wnt-pathway-dependent cancers is identified
Thursday 17 September 2009
A new compound has been identified that could play a role in treating cancers that are dependent on a complex network of proteins known as the Wnt signalling pathway. The findings were reported in the science journal, Nature.
Location
United States
See map: Google Maps
Scientists identify three genes that are risks for Alzheimer’s disease
Monday 7 September 2009
Scientists from the UK and France have identified three genes that appear to increase a person’s chances of developing Alzheimer’s disease, the most common cause of dementia.
Location
United Kingdom
See map: Google Maps
Researchers discover two broadly neutralising antibodies against HIV
Friday 4 September 2009
Researchers from industry and two non-profit organisations have reported the discovery of two new broadly neutralising antibodies against the human immunodeficiency virus (HIV), thus advancing the goal of developing an AIDS vaccine.
Location
United States
See map: Google Maps
Select a News Category
Recent Appointments
Tim Edwards elected chairman of BIA
Tuesday September 7 2010
Index Ventures appoints antibody expert as partner
Friday September 3 2010
Colin Stewart appointed CEO at Amarin
Friday August 20 2010
Karl Keegan nominated as CFO of Pharming
Friday August 20 2010
Axel Müller becomes CEO at SkyePharma
Thursday August 19 2010